TY - JOUR
T1 - Cross-border spread of blaNDM-1- And blaOXA-48 positive Klebsiella pneumoniae
T2 - A European collaborative analysis of whole genome sequencing and epidemiological data, 2014 to 2019
AU - Ludden, Catherine
AU - Lötsch, Felix
AU - Alm, Erik
AU - Kumar, Narender
AU - Johansson, Karin
AU - Albiger, Barbara
AU - Huang, Te Din
AU - Denis, Olivier
AU - Hammerum, Anette M.
AU - Hasman, Henrik
AU - Jalava, Jari
AU - Räisänen, Kati
AU - Dortet, Laurent
AU - Jousset, Agnès B.
AU - Gatermann, Sören
AU - Haller, Sebastian
AU - Cormican, Martin
AU - Brennan, Wendy
AU - Grosso, Maria Del
AU - Monaco, Monica
AU - Schouls, Leo
AU - Samuelsen, Ørjan
AU - Pirš, Mateja
AU - Cerar, Tjaša
AU - Oteo-Iglesias, Jésus
AU - Pérez-Vázquez, Maria
AU - Sjöström, Karin
AU - Edquist, Petra
AU - Hopkins, Katie L.
AU - Struelens, Marc J.
AU - Palm, Daniel
AU - Monnet, Dominique L.
AU - Kohlenberg, Anke
N1 - Publisher Copyright:
© 2020 European Centre for Disease Prevention and Control (ECDC). All rights reserved.
PY - 2020/5/21
Y1 - 2020/5/21
N2 - Analysis of sequencing data for 143 blaNDM-1- and blaOXA-48-positive Klebsiella pneumoniae isolates from 13 European national collections and the public domain resulted in the identification of 15 previously undetected multi-country transmission clusters. For 10 clusters, cases had prior travel/hospitalisation history in countries outside of the European Union including Egypt, Iran, Morocco, Russia, Serbia, Tunisia and Turkey. These findings highlight the benefit of European whole genome sequencing-based surveillance and data sharing for control of antimicrobial resistance.
AB - Analysis of sequencing data for 143 blaNDM-1- and blaOXA-48-positive Klebsiella pneumoniae isolates from 13 European national collections and the public domain resulted in the identification of 15 previously undetected multi-country transmission clusters. For 10 clusters, cases had prior travel/hospitalisation history in countries outside of the European Union including Egypt, Iran, Morocco, Russia, Serbia, Tunisia and Turkey. These findings highlight the benefit of European whole genome sequencing-based surveillance and data sharing for control of antimicrobial resistance.
UR - https://www.scopus.com/pages/publications/85085589891
U2 - 10.2807/1560-7917.ES.2020.25.20.2000627
DO - 10.2807/1560-7917.ES.2020.25.20.2000627
M3 - Review article
SN - 1025-496X
VL - 25
JO - Eurosurveillance
JF - Eurosurveillance
IS - 20
ER -